Investment

LINEAGE CELL THERAPEUTICS IN

Historical 13F holders

CUSIP
53566P109
Type
Equity
Class
COM
Period 13F filings
2026 Q1 5
2025 Q4 8
2025 Q3 7
2025 Q2 6
2025 Q1 6
2024 Q4 5
2024 Q3 5